Member Info for Wiggly

Moookshood, any guesstimate on potential revenues?

Glasgow viral uni on news assessing cv, vaccines, drugs, therapies etc

Israel, Melbourne, Spain, Leceister...

These lock downs are unaffordable.

The world needs an alternative solution asap

No news is good news. Each project continues to develop at pace and this will become a bit like a pressure cooker ready to blow. I wouldn't be surprised to see double digit % increases prior to news landing. >200P would be a great base to receive block buster news.

In 5 minutes, Hopefully!

If the professor is right, I'd say it is probable that Avct are in active talks

Given the excellent performance of these novel reagents in the assays, and the other benefits of Affimer reagents, there should be considerable interest from potential partners in developing them as a therapy for COVID-19.”

Would love for Avacta to drop an rns to inform that they are in active discussions with several unnamed parties.

Should read...

Sona has NOW 70 Bagged vs avct at 7 bags

SONA has not 70 bagged vs AVCT 7 bags.

Which company has the better COVID test(s)?

Which company has the better non COVID pipeline?

Ladies and Gents,

Sona started the year at 0.12 CAD per share. They now trade at >8.25 CAD per share...and rising!

AVCT has a long way (multi bags from this point) to run to catch SONA.

Lets not forget, 130% rise on news released Friday.

ACVT will surely follow when news lands. The question is, what will be our base for news landing?

Thanks Tl. I am surprised there is not more debate on this subject.

Will ava6000 work as well in humans as it does in mice? What are the main risks factors driving performance and safety in humans?

If the risk is low (meaning ava 6000 is very likely to perform well in humans) then huge value for avct is highly probable.

Keen to hear from any experts.

Another question...

When testing in animals (Mice in this case) is so unquestionably favourable, does the probability of success when deploying with humans increase?

Are there any similar technologies that have been deployed to humans with no adverse / adverse effects?

News or no news I think there will be a big immediate rise, unlike the past few weeks.

The Sona news will have opened eyes to the very real and very huge potential that Avct is on the cusp of delivering.

With awareness now of the Sona LFT accuracy, Anyone that watched the webinar hosted by Cytiva, avct and Sona will now feel extremely confident in the news to come from avct.

Started the year at 0.12 Cad per share. They now trade at 7.00 cad per share.

Incredible.

Hopefully avct do the same.

Monday would be a very nice day to release a blockbuster rns however I'm be happy for another week of no news, letting this build strongly in anticipation of that big rns.

I don't think so Timster. Id be quite happy for no news next week and to see this start to build on speculation/sentiment. For sure the tide has now turned. Major news gets closer each day.

MM not prepared to sell anymore before the weekend but will take entire holding at the offer price!

Make your own mind up!

Cytiva//Klaus said they were VERY encouraged by the initial data. Not just encouraged, but VERY encouraged.

Exciting.

Very likely that we are 'optimising' from a >96% baseline, targeting >98%.

The rise over at SONA is nothing compared to what will happen here - with all of the follow on potential related to the Affirmer tech.